The Journal
Unlocking the
aesthetics arena.
The studies that move the field. The regulation you'll need to act on. The claims that don't survive scrutiny. Concise, referenced, written for working clinicians.
Earlier pieces
Regulation
9 September 2026
Documenting CPD for NMC Revalidation: What Counts and How to Record It
The NMC requires 35 hours of CPD over three years, at least 20 of them participatory. For aesthetic nurses, the challenge is rarely doing the CPD. It is documenting it correctly as it happens.
Regulation
2 September 2026
JCCP Standards in Practice: What Ongoing Compliance Requires
Registration with the JCCP is the starting point, not the finish line. Here is what the Standards Framework actually asks of you week to week.
Business
2 September 2026
Treatment Calendars, Retention, and Predictable Income in Aesthetic Practice
Most aesthetic practitioners price by the individual treatment and market for new clients. A more stable income comes from retained clients, structured treatment plans, and a calendar built on clinical logic.
Clinical
26 August 2026
Acne in Darker Skin Tones: Consultation Priorities for UK Aesthetic Practitioners
The pathophysiology of acne is the same across all skin tones. The consultation is not. PIH risk, treatment tolerance, and the sequencing of interventions each need to be adjusted when working with Fitzpatrick IV to VI skin.
Ingredient science
20 August 2026
Tyrosinase Inhibitors for Hyperpigmentation: Clinical Evidence
Compare hydroquinone, azelaic acid, kojic acid, arbutin and niacinamide by mechanism, evidence, limitations and clinical role in UK practice.
Clinical
19 August 2026
Rosacea Trigger Mapping: A Subtype-Specific Approach for Aesthetic Practice
Rosacea triggers differ by subtype. Use a structured mapping framework to improve consultation quality, patient guidance and treatment planning decisions.
Business
19 August 2026
Setting Your Consultation Fee: A Pricing Framework for UK Aesthetic Practitioners
Set an aesthetic consultation fee using costs, clinical value and positioning. A practical pricing framework for UK practitioners who are undercharging.
Treatments
18 August 2026
Hormonal Melasma: OCP, HRT, and Perimenopause in Practice
Oral contraceptives, HRT, and perimenopause are the main hormonal drivers of melasma. Here is what the clinical evidence shows for UK aesthetic practitioners.
Regulation
12 August 2026
Writing NMC Revalidation Reflective Accounts as an Aesthetic Nurse
The NMC requires five written reflective accounts by revalidation. Most nurses find the blank page harder than the reflection itself. This is a practical framework for writing accounts that work, with examples from aesthetic practice.
Clinical
12 August 2026
Acne Morphology and Treatment Selection: What Practitioners Miss in the Consultation
Targeting the wrong acne lesion type is the most common reason treatment fails. This is how to read acne morphology and build a treatment plan that matches your patient's presentation.
Treatments
9 August 2026
Chemical Peels for Hyperpigmentation: Timing, Depth and Evidence
Chemical peels reduce hyperpigmentation by accelerating epidermal turnover. What the evidence shows on timing, depth, and the autumn correction window.
Treatments
6 August 2026
PIH vs PIE: How to Tell Them Apart with the Blanch Test
PIH is melanin and holds its colour under pressure; PIE is vascular and blanches. The blanch test, dermoscopy and Wood's lamp steps that tell them apart.
Regulation
5 August 2026
JCCP Registration for Aesthetic Practitioners: What It Proves
JCCP registration is a voluntary standards signal, not a national licence. Here is what the register verifies and how to prepare your evidence.
Clinical
5 August 2026
Acne Scarring in Aesthetic Practice: Classification, Assessment and Treatment Planning
Treating acne scarring without classifying the scar type first is one of the most common clinical errors I see in practice. Here is the assessment framework that should precede every treatment decision.
Ingredient science
4 August 2026
Visible Light in Melasma: When UV-Only SPF Is Not Enough
Visible light drives melanocyte activity even where UV is blocked. Here is what the clinical evidence shows for iron oxide tinted SPF in melasma management.
Treatments
2 August 2026
Solar Lentigines vs Melasma: Differential Diagnosis in Practice
Solar lentigines and melasma are often confused, but they require different protocols. Here is how UK aesthetic practitioners can tell them apart clinically.
Clinical
29 July 2026
Rosacea Barrier Recovery After Aesthetic Treatment: The Protocol Your Clients Need
In rosacea skin, the barrier is already compromised before any treatment begins. IPL, chemical peels and laser each create an additional disruption. What the recovery window looks like, and how to manage it.
Business
29 July 2026
Lifetime Patient Value in Aesthetic Practice: The Number Most Practitioners Have Never Calculated
Most aesthetic practitioners know what each appointment earns. Very few know what a patient relationship is worth over three or four years. That number changes every business decision in a practice.
Ingredient science
23 July 2026
Tranexamic Acid for Hyperpigmentation: What the Evidence Shows
Topical tranexamic acid is one of the best-evidenced agents for melasma and PIH. Here is what the clinical literature shows for UK aesthetic practitioners.
Clinical
22 July 2026
Demodex Folliculorum and Rosacea: What UK Aesthetic Practitioners Need to Know
Elevated Demodex density is a consistent finding in papulopustular rosacea. Practitioners who understand the evidence can assess more accurately, refer more confidently, and support better long-term outcomes.
Clinical
22 July 2026
Acne After Antibiotics: Microbiome Considerations for UK Aesthetic Practitioners
Acne persisting after antibiotics needs careful reassessment. Review the microbiome evidence, NICE stewardship and next steps for UK aesthetic practitioners.
Regulation
16 July 2026
Consent in Aesthetic Practice: What GMC and NMC Require in 2026
Informed consent in UK aesthetic practice is governed by GMC, NMC, and JCCP requirements. What valid consent looks like, and what your records must show.
Clinical
15 July 2026
Melasma in Aesthetic Practice: Differential Diagnosis and the UK Evidence Base
Melasma is often mismanaged in aesthetic practice. Learn the differential diagnosis, assessment priorities and UK evidence that should shape treatment planning.
Clinical
15 July 2026
Hormonal Acne in Adult Women: Recognising the Pattern and Adapting Your Treatment Plan
Adult female acne has a different pattern from teenage acne. Learn how UK aesthetic practitioners should adapt assessment and treatment planning.
Regulation
12 July 2026
Aesthetic Practitioner Scope of Practice: 2026 UK Guide
Scope of practice in UK aesthetics depends on registration, competence, medicines law and the treatment offered. Here is how to assess your position.
Regulation
9 July 2026
Remote Prescribing in Aesthetic Practice: The 2025 UK Rules
UK regulators banned remote prescribing for cosmetic POMs in 2025. NMC, GMC and JCCP all require face-to-face assessment before botulinum toxin is prescribed.
Business
8 July 2026
Building Consistent Monthly Income in Aesthetic Practice: Getting the Structure Right in 2026
Unpredictable monthly income is the most common financial complaint I hear from aesthetic practitioners. It is rarely a demand problem. It is almost always a structure problem.
Clinical
8 July 2026
Antibiotic Stewardship in Acne: What UK Aesthetic Practitioners Need to Know in 2026
NICE acne guidance sets clear limits on antibiotic use. Learn what UK aesthetic practitioners should check, document and refer to support stewardship.
Regulation
7 July 2026
NMC Revalidation for Aesthetic Nurses: The 2026 Guide
NMC revalidation requires 450 practice hours, 35 CPD hours and five reflective accounts every three years. What nurses in aesthetic practice need to prepare.
Regulation
5 July 2026
Record Keeping in Aesthetic Practice: UK Requirements 2026
UK law, UK GDPR, the NMC Code, and JCCP standards all shape medical record keeping in aesthetic practice. What every UK practitioner must know for 2026.
Regulation
2 July 2026
CQC Registration for Aesthetic Practices: When It Applies
CQC registration and aesthetic licensing are separate requirements. Here is when aesthetic practices in England need to register with the Care Quality Commission.
Clinical
1 July 2026
Rosacea Subtype Classification: The Assessment That Shapes Every Treatment Decision
Accurate rosacea subtype classification at consultation is the decision that determines the whole treatment plan. Here is how to do it correctly in aesthetic practice.
Clinical
1 July 2026
Post-Inflammatory Hyperpigmentation Treatment: Building a Protocol That Works
PIH treatment stalls when the protocol is not built to match the client's skin type, the depth of the pigment, and the underlying trigger. The assessment comes first.
Regulation
30 June 2026
Do You Need a Level 7 Qualification to Practise Aesthetics?
A Level 7 qualification is not yet a universal legal requirement to practise aesthetics in the UK, but it is the standard the regulation is moving toward.
Regulation
30 June 2026
Aesthetic Practitioner Indemnity Insurance: What You Need
JCCP, CPSA and NMC standards require indemnity that matches your treatment list. The £1m and £5m per-claim benchmarks and the gaps that catch clinics out.
Regulation
28 June 2026
Botox and Fillers for Under-18s: What the 2021 Act Requires
It has been a criminal offence to give cosmetic botox or fillers to under-18s in England since 2021. What the Act covers and what age verification requires.
Regulation
25 June 2026
JCCP Standards for Aesthetic Practitioners: What to Have in Place
JCCP registration is voluntary. Here is what its professional standards cover, how to evidence them and what government has not yet made mandatory.
Clinical
24 June 2026
The Hyperpigmentation Consultation: A Clinical Framework for Aesthetic Practitioners
Hyperpigmentation is not a single condition. Getting the consultation right means knowing which type you are treating before you choose any active ingredient or procedure.
Clinical
24 June 2026
Building an Acne Treatment Plan: What UK Aesthetic Practitioners Need to Know
Build an acne treatment plan around structured assessment, NICE NG198, referral thresholds and the evidence relevant to UK aesthetic practice.
Regulation
21 June 2026
Informed Consent for Aesthetic Treatments: What UK Law Requires
Informed consent for aesthetic treatments is a two-stage process. What JCCP standards and UK regulators require practitioners to document and get right.
Regulation
18 June 2026
Advertising Injectables in the UK: ASA and MHRA Rules Explained
UK practitioners cannot advertise botulinum toxin to the public. Here is what ASA and MHRA rules actually prohibit, and what your clinic can say instead.
Clinical
17 June 2026
Rosacea and Barrier Function: The Clinical Link Practitioners Miss
Barrier dysfunction is central to rosacea. Learn how it changes assessment, treatment sequencing, skincare recommendations and long-term results.
Ingredient science
16 June 2026
Niacinamide in Aesthetic Practice: The Clinical Evidence
Niacinamide is among the most-studied topical actives in aesthetic practice. What peer-reviewed evidence supports for hyperpigmentation, acne, and skin barrier.
Ingredient science
14 June 2026
Polynucleotide Injectables: What the Evidence Shows in 2026
Polynucleotide injectables are the most-discussed regenerative treatment in UK aesthetics. What the evidence actually supports, and what it does not.
Business
10 June 2026
Aesthetics Business Income in the UK: What Practitioners Are Actually Earning in 2026
Most aesthetic practitioners are earning less than their skills and training should command. The income gap is structural, not clinical. Here is what it looks like and how practitioners are closing it.
Clinical
10 June 2026
The Acne Microbiome: What UK Aesthetic Practitioners Need to Know
Acne is not a single-organism disease. Understanding microbial diversity, strain differences, and treatment interactions changes how you approach acne assessment in aesthetic practice.
Ingredient science
9 June 2026
Topical Peptides in Aesthetic Practice: What the Evidence Shows
Topical peptides are widely marketed in aesthetic skincare. Review the clinical evidence, formulation limits and questions UK practitioners should ask.
Ingredient science
4 June 2026
Topical Vitamin C in Aesthetics: What the Evidence Shows
Topical vitamin C has more peer-reviewed evidence behind it than most active ingredients in aesthetic skincare. Here is what the literature actually supports.
Regulation
3 June 2026
Exosomes in Aesthetics: What the Evidence and Regulators Say
Exosomes are the most-marketed product in aesthetics right now. What the clinical evidence actually supports, and where UK and FDA regulators draw the line.
Treatments
28 May 2026
Glycolic Acid Peels in UK Aesthetic Practice: The Evidence
Glycolic acid peels are among the best-evidenced superficial procedures in UK aesthetic practice. What the evidence shows for acne, PIH, and photoaging.
Regulation
24 May 2026
NMC Prescribing Standards for Cosmetic Injectables 2025
From June 2025, NMC registrants must consult face-to-face before prescribing cosmetic injectables. Here is what changed and what compliance requires.
Ingredient science
21 May 2026
Retinoids in UK Aesthetic Practice: The Clinical Evidence
Topical retinoids in UK aesthetic practice: what the peer-reviewed evidence supports, where the prescribing boundary sits, and how to apply them clinically.
Treatments
12 May 2026
Rosacea Treatment in Aesthetic Practice: 2026 Evidence
Rosacea treatment for UK aesthetic practitioners: what each subtype responds to, where the evidence base sits, and where scope of practice begins and ends.
Ingredient science
10 May 2026
Azelaic Acid for UK Practitioners: The Full Clinical Picture
Azelaic acid is licensed for rosacea and acne in the UK. Here is what the evidence supports across all three indications and what practitioners need to know.
Regulation
2 May 2026
England Aesthetics Licensing: What Is Law and What Is Proposed
England has no national aesthetics licence in force. Here is what section 180 permits, what government has proposed and which current rules still apply.
Treatments
30 April 2026
Vascular Occlusion in Hyaluronic Acid Filler: UK Practitioner Protocol
Vascular occlusion hyaluronic acid filler UK: recognition, hyaluronidase protocol, prescribing duties and the documentation a defensible practitioner needs.
Studies
30 April 2026
NICE Acne Guidelines (NG198) for Aesthetic Practitioners
NICE NG198 sets three acne severity bands, 12-week first-line combinations and referral thresholds. Here is where aesthetic practitioner scope ends.
Regulation
30 April 2026
MHRA Botox Advertising Rules: What UK Clinics Can Say
Botulinum toxin is a prescription-only medicine, so Regulation 284 bans advertising it to the public. What a UK clinic website and social feed can say.
Treatments
28 April 2026
Vascular Occlusion After Filler: Recognition and Response
Vascular occlusion after HA filler is time-critical. The recognition hierarchy, the ninety-minute window, and scope of practice for UK aesthetic practitioners.
Treatments
28 April 2026
Microneedling Evidence in 2026: What UK Practitioners Should Know
Microneedling in 2026: where the peer-reviewed evidence actually sits, where it is still thin, and what UK practitioners need to know.
Editorial
27 April 2026
Why this exists. What you'll get from it.
The studies that matter. The regulation that's changing. The claims that don't survive a primary source, for working clinicians.
New here?
Join free. No subscription.
Put your name down, it is completely free, no subscription and no card. You get a login by email, first sight of new courses, and offers when they run.